HF 4504 – Minnesota

Status: Inactive / Dead
Year Introduced: 2022
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF4504&ssn=0&y=2022

Prescription drug price transparency provisions modified. Proposed changes: (13) if the prescription drug was acquired by the manufacturer during the previous
12-month period, all of the following information:
(i) price at acquisition;
(ii) price in the calendar year prior to acquisition;
(iii) name of the company from which the drug was acquired;
(iv) date of acquisition; and
(v) acquisition price.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found